49
Participants
Start Date
November 30, 2017
Primary Completion Date
May 10, 2019
Study Completion Date
May 10, 2019
HNO Donor
Infusion
Nitroglycerin (NTG)
Infusion
Placebo
Infusion
Inova Heart and Vascular Institute, Falls Church
Duke Advanced Heart and Lung Failure Clinic, Durham
Northwestern Medicine, Chicago
Orange County Research Center, Tustin
Local Institution, Suita-shi
Indiana University School of Medicine-Indianapolis, Indianapolis
Brigham and Womens Hospital, Boston
Local Institution, Nagoya
Local Institution, Kawasaki
Local Institution, Groiningen
Local Institution, Edinburgh
Local Institution, Glasgow
Local Institution, Glasgow
Local Institution, Glasgow
Local Institution, Harrow
Local Institution, London
Local Institution, London
Local Institution, London
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY